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models. A checklist based on critiques of recent HTAs will be a useful tool for manu-
facturers when selecting relevant HRQoL parameters.
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suicide seVeRiTy RaTing scale in asia-Pac
Anderson H.1, Gordon-Stables R.1, Wild D.1, Riale K.2
1ICON plc, Oxford, UK, 2ERT, pittsburgh, pA, USA
Objectives: The Columbia Suicide Severity Rating Scale (C-SSRS) has been devel-
oped into an electronic self-rated version (the e-CSSRS) in order to facilitate compli-
ance with regulatory requirements for prospective monitoring of suicidal ideation 
and behaviours. The e-CSSRS v2.0 for IVRS has been translated and linguistically 
validated for use in over 60 countries. Whilst translating and linguistically validating 
the scale it was noted that particularly in the Asia-Pacific region there were some 
challenging issues around the concept of suicide from a linguistic and cultural 
perspective. This study aimed to determine what these issues were and highlight 
how they were resolved. MethOds: Eighteen reports were reviewed from the Asia-
Pacific region. The languages were: China-Mandarin, India-English, India-Gujarati, 
India-Hindi, India-Kannada, India-Malayalam, India-Marathi, India-Tamil, India-
Telugu, Korea-Korean, Malaysia-English, Malaysia-Malay, Malaysia-Mandarin, 
Philippines-English, Philippines-Tagalog, Singapore-English, Singapore-Malay, and 
Singapore-Mandarin. Each report was reviewed for challenges relating to translation 
and cultural adaptation. Results: Across all reports specific homonymic confu-
sions were encountered within two target languages: in Indian Hindi the same 
word is used for “pill” and “bullet”; in Singapore Malay the words for “end” and 
“saving” sound similar, occasioning confusion in prompts about attempts to end 
life. Translations were adapted to avoid these confusions. In two cases the use of 
a gun in suicide attempts was found to be rare or unknown: in Singapore English 
the relevant prompt was clarified to minimise confusion; for Malayalam for Kerala, 
where shooting is rare and hanging is common, “getting a gun” was changed to 
“getting a rope” wherever it appeared and for similar reasons “collecting pills” was 
changed to “collecting a poison.” cOnclusiOns: The e-CSSRS v2.0 IVRS is now 
available in for use in over 60 countries. Some issues were identified relating to 
translation and the methods of suicide in a small number of languages but these 
were resolved throughout the linguistic validation process.
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fRoM clinically ReleVanT ouTcoMe MeasuRes To QualiTy of life  
in ePilePsy
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Objectives: Utilities can be easily derived using generic quality of life (QoL) instru-
ments. However, problems in collecting utility scores may occur because clinical 
evaluations still favor disease specific instruments over generic quality of life instru-
ments for reasons of sensitivity and reliability. Especially in case of the fluctuating 
nature of seizures in epilepsy, generic QoL-instruments are often find to be unsuit-
able for outcome research. A proposed method to bridge the gap between clinically 
relevant outcome measures and QoL is to derive utility scores for epilepsy health 
states. The aim of this study is to develop a scoring algorithm to transform epilepsy 
health states into utility scores. MethOds: The proposed scoring algorithm was 
based on valuations of health states generated by the Time Trade-Off (TTO) method. 
The TTO was based on clinically important attributes (seizure frequency, seizure 
severity and treatment related side-effects). A full factorial design was used which 
resulted in 78 scenario’s. Besides standard demographics, every participant was 
asked to value 10 or 11 different health states. A multilevel regression analysis was 
performed to account for the nested structure of the data. The TTO was conducted 
using online survey software. Results: In total 531 subjects of the general popula-
tion, with an average age of 42 years, have participated in the TTO study. Preliminary 
results show that the best health state (no seizures and no side-effects) is estimated 
at 0.89 utility and the worst state (seizures twice a day, many side-effects, type 5 
seizure) is estimated at 0.16. cOnclusiOns: This study provides a scoring algo-
rithm for transforming clinically relevant outcome measures of epilepsy into utility 
estimates which can be incorporated into economic evaluations. Although seizure 
frequency is the most commonly reported primary outcome measure in epilepsy 
research, this study suggest that the impact of seizure severity alone should not 
be underestimated.
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Objectives: Several national health technology assessment (HTA) bodies including 
the National Institute for Health and Care Excellence (NICE) for England and Wales 
recommend EQ-5D as the preferred health-related quality of life (HRQL) measure for 
use in cost-effectiveness analyses. This study aims to evaluate the recommendation 
and impact of using EQ-5D-5L versus EQ-5D-3L for cost-effectiveness modeling in 
HTA submission guidelines and subsequent reimbursement decisions. MethOds: 
A targeted review of national HTA submission modeling guidelines since the intro-
duction of the EQ-5D-5L measure was carried out for the UK and France. The cost-
effectiveness modeling guidelines were assessed for the requirements for EQ-5D at 
either level. The impact of guideline requirements on submissions were analysed 
by examining the presence of EQ-5D-5L in the 20 most recent technical appraisal 
manufacturer submissions for each HTA body. Results: While all HTA bodies rec-
ommended the use of EQ-5D as a generic measure of HRQL, only NICE specifically 
recommended EQ-5D-5L. However, it was not a requirement. Of the latest published 
guidance only NICE and the Scottish Medicines Consortium had one EQ-5D-5L sub-
mission each. Despite evidence suggesting increased sensitivity and reduced ceiling 
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Objectives: To investigate the extent to which two different modes of adminis-
tration (interview by a trained interviewer versus self-administration) yielded a 
comparable estimate of health-related quality of life (HRQL) in pulmonary tuber-
culosis (PTB) patients. MethOds: The study was conducted between September 
1st 2012 and July 31st 2013, among consecutive PTB patients treated at Thoracic and 
Respiratory Disease Specialist Centre in Baghdad, Iraq. The mode of administration 
of the Functional Assessment of Chronic Illness Therapy-Tuberculosis (FACIT-TB); 
a new tuberculosis (TB) -specific instrument, at baseline was registered in 305 sub-
jects. Results: Although the FACIT-TB was designed for self-administration, most 
patients in our sample (N = 193,63.278%) requested some help from the interviewer 
to fill out the questionnaire. Mann Whitney U test showed that those patients capa-
ble of self-administration were younger (38.16 ± 12.93 versus 43.58 ± 16.41 years, p 
= 0.005) and required less time to complete the questionnaire compared to those 
who interviewed by a trained interviewer (14.64 ± 3.24 versus 17.22 ± 2.61 minutes, 
p < 0.001), while Chi-Square statistics showed that this group of patients had a 
higher education level (p < 0.001). No differences in gender were observed. HRQL 
score across all domains for those who interviewed by a trained investigator was 
slightly lower than those who answered the questionnaire by self-administration. 
However, the results did not reach statistical significance (p> 0.05). cOnclusiOns: 
Technical equivalence has been demonstrated in the sample of PTB patients in Iraq. 
FACIT-TB instrument is flexible and it is able to accommodate the needs of patients 
with diverse social, educational, and functional skills. Technical equivalence across 
different modes of administration of questionnaire permits unbiased assessment 
of the impact of the disease and its treatments on patients’ HRQL.
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a self-adMinisTeRed iPad aPPlicaTion
Yuce D., Hayran M., Kilickap S., Erman M., Celik I.
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Objectives: Cancer has the second highest mortality rates after cardiovascular dis-
eases in the world. Advances in treatment options caused significant enhancements 
in survival of cancer patients. However, the major parameter affecting treatment 
success and treatment adherence in these patients is the quality of life (QoL). We 
aimed to develop a self-administered iPad application for evaluation of QoL in a 
short questionnaire. MethOds: As part of routine practice in Preventive Oncology 
Department EORTC QLQ-C30 was administered to 1549 cancer patients treated in 
Hacettepe University Oncology Hospital. We determined 10 questions that explains 
most of the variation in QoL using factor analysis, and designed a new application 
for iPad, where patients can record responses themselves. Results: The 10 factors 
that described by the factor analysis had the power of 74,2% explaining QoL vari-
ances. The reliability analysis of these factors showed a Cronbach alpha coefficient 
of 0,75. The new self-administered iPad application was tested in a pilot study that 
conducted in 127 patients taking chemotherapy regimens in the outpatient setting. 
The validity and reliability analyses revealed that the new application can be effec-
tively used in Turkish cancer patients. cOnclusiOns: Our results revealed that our 
software application will be useful and efficient for monitoring of the changes in 
QoL during their treatment course. Furthermore, this kind of mobile applications 
may be practical for health professionals in daily routine clinical assessments of 
patients. Also, the audio and visual enhancements in electronic applications provide 
increased accessibility for the cancer patients.
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Objectives: Incorporation of health-related quality of life (HRQoL) evidence into 
economic models is a requirement of many countries for the purposes of Health 
Technology Assessment (HTA), and therefore appropriate health state utility values 
(HSUVs) are often sought. The objective of this review was to: (i) identify and sum-
marise the principal limitations of HSUVs used in recent submissions appraised 
by the National Institute for Health and Care Excellence (NICE) and (ii) produce 
a categorical checklist that can be used by manufacturers to reduce uncertainty 
when selecting HSUVs for HTA. MethOds: Evidence appraisal documents for the 
50 most recently published technologies assessed by NICE were retrieved in June 
2014. Economic models were assessed and utility inputs reviewed. Critiques of the 
utilities reported by the evidence review group or final appraisal committee were 
extracted, reviewed and categorised. Results: Of the appraisals reviewed (43 single 
technology appraisals (TAs) and 7 multiple TAs), utility inputs were either sourced 
from the literature (n= 27), published mapping algorithms (n= 11), de novo mapping 
algorithms (n= 2), or derived from clinical trials (n= 10). The concerns expressed by 
review groups can be categorised into four categories: (i) generalisability – relevance 
of HSUVs to UK clinical practice, deviation from NICE scope, and the use of other 
countries’ valuations for health states; (ii) HSUV selection – inadequate justification 
of HSUVs, and lack of consideration for covariates and disutilities; (iii) mapping algo-
rithms – use of non-validated or non-peer-reviewed publications, incomplete report-
ing of key model information, and ambiguity regarding selection and justification 
of mapping function; (iv) risk of bias – sample size, instrument response rates, and 
general study quality identified as factors affecting HSUV validity. cOnclusiOns: 
The selection of appropriate HSUVs is critical to reduce uncertainty in economic 
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feedback on a 4 point scale for applicability, comprehensibility and appropriateness 
of the response options of each item. They were also encouraged to leave free-text 
feedback. Results: A total of 218 subjects provided feedback, 61.47% female. Mean 
age was 55.78 years, with patients from 18-80 years, 40.37% between 55-65 years. 
The most represented conditions were Parkinson’s (27), Fibromyalgia (23), Multiple 
Sclerosis (20) and Rheumatoid Arthritis (19). The mean number of quantitative 
assessments per item was 55.74, while the mean number of comments was 11.64. 
Considering a cut-off of 2 points in the 0-3 scale, 18 items had low applicability, 
just one item had low comprehensibility and all items had appropriate response 
options. cOnclusiOns: An impressive amount of feedback was obtained in just 
a week using the Open Research Exchange platform. The lowest scores were in 
applicability. However, as the items are destined to an adaptive test, some of them 
are very extreme (destined to severe cases). Therefore applicability was considered 
a secondary concern. With this caveat, quantitative feedback was very positive, and 
added to the great amount and detail of qualitative feedback suggest some changes 
that we think will greatly improve the instrument.
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QualiTy of life in PaTienTs undeRgoing heModialysis: a Vision of The 
influence of TiMe
Maia R.C.F.1, Monteiro W.M.S.1, Silva M.G.C.2, Almeida R.F.C.1
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Objectives: To measure and compare the quality of life in patients undergoing 
hemodialysis with respect to time. MethOds: An observational, prospective study 
conducted in 2012/2013 consisting of 50 patients with Terminal Chronic Kidney 
Disease, undergoing HD in a public clinical care within the metropolitan area of 
Fortaleza. We used the KDQOL instrument early in therapy and one year after its 
beginning in order to observe changes in quality of life over time. Statistical analy-
sis included frequency distribution and measures of central tendency. Results: 
The general dimensions of this instrument indicate that the dimensions “physical 
function”, “social function” and “emotional function” had the lowest scores early 
in therapy. It is observed that these same dimensions showed significant improve-
ments in patients after one year of HD. Only “general health” was not significant. 
At baseline, specific dimensions of the instrument as “professional role”, “sexual 
function” and “disease overload” have the lowest scores and remain the same after 
one year of the begin of therapy, showing that the time difference has no statistical 
significance. cOnclusiOns: The quality of life of patients undergoing hemodialysis 
after a year of therapy is superior to the quality of life showed at the beginning of 
treatment although this difference is not statistically significant. It is important 
to search for alternatives that can positively influence the quality of life of these 
patients.
PRM177
MeThods used To MeasuRe PaTienT PRefeRences in PsoRiasis 
TReaTMenTs – an oVeRView wiTh RegaRds To The geRMan iQwig  
and g-ba
Gutknecht M., Herrlein O., Augustin M.
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Objectives: According to the methodology of the German Institute for Quality 
and Efficiency in Healthcare (IQWiG), the benefit assessment of a new treatment 
intervention refers to patient-reported outcomes exclusively. Given the existence of 
different patient-relevant outcomes the Federal Joint Committee (G-BA) can engage 
the IQWiG to aggregate these to one comprehensive benefit measurement. So far, 
the IQWiG uses no standardized method for this. In its current method paper, among 
the benefit QALY, the IQWiG refers to methods of multi-criteria decision making 
or preference evaluation like analytic hierarchy process and conjoint analysis. For 
psoriasis, one of the most frequent chronic skin diseases worldwide, a variety of 
treatment interventions is available. In the light of recent discussions, the objective 
was to give an overview of methods which have been used to date to prioritize and 
weight patient-relevant outcomes in psoriasis treatment. MethOds: The present 
review is based on a systematic literature research until 31 December 2013 in the 
databases PubMed, Embase, Ovid Medliner, Cochrane Library, EconLit and CINAHL 
using the keywords “psoriasis” and “preferences”. Results: The search resulted in 
288 hits without duplicates. 16 articles met the predefined inclusion criteria. In addi-
tion to methods to calculate QALY like time-trade off and standard gamble, conjoint 
analysis, willingness-to-pay and other preference methods were used. In view of the 
method paper of IQWiG, no study exists in the field of psoriasis where the analytic 
hierarchy process was used. cOnclusiOns: The results of the presented review 
show, that the analytic hierarchy process was not used in psoriasis studies, so far. 
The use of this method in future studies might provide new essential knowledge 
in the evaluation of patient preferences in psoriasis treatment.
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Objectives: The QUALIOST (quality in life questionnaire in osteoporosis) is one of 
the most commonly used osteoporosis-specific health-related quality of life (HRQoL) 
questionnaires and it is often used in clinical studies to document the longitudinal 
impact of osteoporosis and related fractures. It is unknown whether the QUALIOST is 
better at estimating HRQoL for osteoporotic fracture patients compared to the com-
monly used EQ-5D questionnaire. Preference scores have not yet been developed for 
the QUALIOST and, thus, cost-utility analyses are difficult to perform. The purpose of 
the present paper is to describe the first steps of a future study on mapping from the 
QUALIOST to the EQ-5D questionnaire. MethOds: A questionnaire, containing both 
EQ-5D-5L and QUALIOST, is distributed to patients in an orthopaedic outpatient clinic 
in Denmark and the aim is to include 150 patients. Patients above 50 years of age and 
with a recent fracture (less than 2 weeks old) are invited to participate in the study. 
effects associated with EQ-5D-5L, this measure is still not a key requirement for cost-
effectiveness modeling in selected HTA submissions. cOnclusiOns: EQ-5D-3L has 
the potential to distort the true cost-effectiveness in conditions that are insensi-
tive to the measure. Awareness and requirements for the use of EQ-5D-5L should 
increase amongst manufacturers and HTA bodies to ensure submissions present 
accurate cost-effectiveness models. Further research into the evaluation of cost-
effectiveness results between these two measures following the introduction of 
validated independent value sets for EQ-5D-5L is encouraged.
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Objectives: In patients requiring frequent blood transfusions due to transfusion 
dependent anemia (TDA) (e.g., sickle cell disease [SCD]) and myelodysplastic syn-
drome (MDS), life expectancy is directly related to the quality of chelation therapy, 
and poor adherence to treatment increases the risk of complications and shortens 
survival1. Improved palatability ratings and gastrointestinal (GI) tolerability could 
have positive impacts on adherence with iron chelation therapy (ICT) 2. Therefore, 
patient-reported outcomes (PROs) measuring compliance, GI symptoms, and pal-
atability were developed and the Satisfaction with Iron Chelation Therapy (SICT) 
questionnaire was modified, as electronic PROs (ePROs) specific to a new formula-
tion of ICT. MethOds: Eleven patients with TDA or MDS provided informed con-
sent and were included in this qualitative study. Two sets of face-to-face cognitive 
interviews were conducted iteratively; modifications to items were debriefed in the 
second set. Interviews began open-endedly to elicit patients’ spontaneous experi-
ences with ICT. Interviews were audio recorded and transcribed. An item tracking 
matrix documented the changes made for each item. Data analysis used ATLAS. ti 
software. This study was conducted according to best practices for development3 
and modification4 of PROs in an ePRO format. Results: Patients were 73% (n= 8) 
male and 27% (n= 3) female with a mean age of 43 (range 14-81 years); 45% (n= 5) had 
SCD, and 27% (n= 3) had MDS. Patient spontaneous reports and cognitive debriefing 
responses confirmed concepts in the draft PROs and helped eliminate irrelevant 
items. Changes made after cognitive debriefing ensured the comprehensibility, lack 
of redundancy, and appropriate instructions and response options. The resultant 
PROs included the Compliance (2 items), GI Symptom Diary (6 items), Palatability (4 
items), and modified SICT (13 items). cOnclusiOns: Results support the content 
validity of PRO measures of compliance, GI symptoms, palatability, and satisfaction 
with ICT. These measures require psychometric validation of validity, reliability, and 
responsiveness before recommending their use in future clinical research.
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The iMPoRTance of MigRaTion assessMenTs: ecoa TRanslaTions and 
linguisTic ValidaTion
Sweeney E., Kelley T.
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Objectives: As the use of clinical outcomes assessments (COAs) in global studies 
continues to increase, early collaboration between eCOA and linguistic validation 
providers becomes critical to the success of global initiatives. Early involvement 
of a linguistic validation partner in the eCOA migration process offers insight into 
migration issues that may not be present in the English version of the instrument, 
but if not identified, can lead to study delays as well as increased costs for the spon-
sor. MethOds: An examination was conducted of previous linguistic validation 
projects that included either newly developed eCOA instruments or pen/paper to 
eCOA migration. A comparison of various eCOA platforms, the corresponding issues, 
and details relating to migration solutions were assessed. Results: Frequently, a 
line of text that is present in an eCOA platform (proprietary software, Excel, etc.) 
is coded such that it populates into the eCOA device in multiple locations. These 
segments are sometimes referred to as “computed text” and are commonly used 
for response options that repeat for multiple items of a questionnaire. While this 
may work adequately in English, many languages require a variance in the transla-
tion used based on the context of the item and/or response choice. While a pen/
paper version may allow for these variances, the initial eCOA programming may 
not. The variance is only determined further into the linguistic validation process 
and presents challenges if the device requires re-programming. cOnclusiOns: A 
migration assessment, separate from equivalency testing, allows for the eCOA and 
linguistic validation providers to assess the initial setup of the eCOA software. This 
assessment can determine whether system modifications are necessary to allow 
for the translations to properly be mapped and displayed. This additional step will 
also prevent study delays as well as quality issues as it allows issues to be addressed 
early and avoid later difficulties.
PRM175
PaTienT dRiVen QuesTionnaiRe deVeloPMenT, iTeM feedback fRoM 
useRs of a PaTienT neTwoRk
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Objectives: CAT-Health is a generic health related quality of life computer adaptive 
test developed and validated in Spain. Based on its 96 item pool, a new instrument 
is being developed in English. The objective of the present study was to obtain 
substantial feedback from patients on the items, through Open Research Exchange 
platform, that centralizes PROM research and is integrated with PatientsLikeMe, 
an online community. MethOds: The item pool was split in four sets of 24 items 
each. 750 patients with various conditions received an e-mail that included link 
to a survey open for 7 days. They were asked to answer one of the sets and give 
